CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 41 enrolled
Drug / intervention
cisplatin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01590017
NCT01590017Phase 2Completed

Feasibility Study of Safety, Toxicity, and Compliance of Concomitant Chemoradiotherapy for HIV-Associated Locally-Advanced Cervical Cancer

AIDS Malignancy Consortium·interventional·Posted May 2, 2012·Updated Jul 27, 2022

In Brief

A Phase 2 clinical trial evaluating cisplatin and external beam radiation therapy for Cervical Cancer and Acquired Immunodeficiency Syndrome. Completed, enrolled 41 participants across 2 sites in 2 countries.

Detailed Summary

RATIONALE: Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x rays to kill tumor cells. Giving cisplatin together with radiation therapy may be an effective treatment for cervical cancer. PURPOSE: This trial studies how well cisplatin and radiation therapy work in treating participants with HIV-associated locally advanced cervical cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSouth Africa, Zimbabwe

Timeline

Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMay 2, 2012
Enrollment StartApr 1, 2014
Primary CompletionApr 20, 2017
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 14.2 years ago

Interventions

cisplatindrug

external beam radiation therapyradiation